| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.195 | 1.597 | 482 | 1.650 | 263 | 217 | 725 | 2.139 | 4.832 | 5.073 |
| Total Income - EUR | 1.195 | 1.597 | 482 | 1.650 | 263 | 217 | 725 | 2.139 | 4.832 | 5.073 |
| Total Expenses - EUR | 38 | 74 | 74 | 93 | 68 | 0 | 67 | 85 | 137 | 1.541 |
| Gross Profit/Loss - EUR | 1.157 | 1.522 | 408 | 1.558 | 196 | 217 | 658 | 2.055 | 4.694 | 3.533 |
| Net Profit/Loss - EUR | 1.121 | 1.472 | 392 | 1.506 | 186 | 210 | 639 | 1.980 | 3.943 | 2.968 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - House Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 661 |
| Current Assets | 5.914 | 7.323 | 7.587 | 8.959 | 8.966 | 9.006 | 9.446 | 5.869 | 9.952 | 11.373 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.084 | 0 |
| Receivables | 0 | 0 | 4 | 0 | 3 | 3 | 3 | 0 | 0 | 1.596 |
| Cash | 5.914 | 7.323 | 7.583 | 8.959 | 8.963 | 9.003 | 9.443 | 5.869 | 8.868 | 9.777 |
| Shareholders Funds | 5.907 | 7.319 | 7.587 | 8.953 | 8.966 | 9.006 | 9.446 | 5.858 | 9.783 | 11.711 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7 | 4 | 0 | 6 | 0 | 0 | 0 | 11 | 169 | 322 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - House Intermed S.r.l.